Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency.


Por: Marin-Bejar O, Romero-Moya D, Rodriguez-Ubreva J, Distefano-Muñoz ME, Lessi F, Aretini P, Liquori A, Castaño J, Kozyra E, Kotmayer L, Bueno C, Cervera J, Rodriguez-Gallego JC, Nomdedeu JF, Murillo-Sanjuán L, De Heredia CD, Pérez-Martinez A, López-Cadenas F, Martínez-Laperche C, Dorado-Herrero N, Marco FM, Prósper F, Menendez P, Valcárcel D, Ballestar E, Bödör C, Bigas A, Català-Temprano A, Wlodarski MW and Giorgetti A

Publicada: 1 sep 2023 Ahead of Print: 1 sep 2023
Categoría: Hematology

Resumen:


Filiaciones:
Marin-Bejar O:
 Regenerative Medicine Program, Bellvitge Institute for Biomedical Research (IDIBELL) and Program for Clinical Translation of Regenerative Medicine in Catalonia (P-CMRC), Barcelona.

Romero-Moya D:
 Regenerative Medicine Program, Bellvitge Institute for Biomedical Research (IDIBELL) and Program for Clinical Translation of Regenerative Medicine in Catalonia (P-CMRC), Barcelona

Rodriguez-Ubreva J:
 Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), Barcelona

Distefano-Muñoz ME:
 Department of Hematology and Oncology, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Barcelona

Lessi F:
 Fondazione Pisana Per la Scienza ONLUS (FPS), San Giuliano Terme

Aretini P:
 Fondazione Pisana Per la Scienza ONLUS (FPS), San Giuliano Terme

Liquori A:
 Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain

 Centro de Investigación Biomédica en Red de Oncología (CIBERONC), Instituto de Salud Carlos III, Madrid

Castaño J:
 Advanced and Cell Therapy Services. Banc de Sang i Teixits, Barcelona

Kozyra E:
 Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine

 Faculty of Biology, University of Freiburg, Freiburg

Kotmayer L:
 HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University. Budapest, Hungary

Bueno C:
 Josep Carreras Leukaemia Research Institute. Department of Biomedicine. School of Medicine, University of Barcelona, Barcelona

Cervera J:
 Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain

 Centro de Investigación Biomédica en Red de Oncología (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain

 Genetics Unit, Hospital Universitario y Politécnico La Fe, Valencia

Rodriguez-Gallego JC:
 Department of Immunology, University Hospital of Gran Canaria Dr. Negrín, Canarian Health System, Las Palmas de Gran Canaria, Spain

 Department of Clinical Sciences, University Fernando Pessoa Canarias, Las Palmas de Gran Canaria, Spain

 Department of Medical and Surgical Sciences, School of Medicine, University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria

Nomdedeu JF:
 Servei d'Hematologia Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, IIB Sant Pau/Josep Carreras Leukaemia Research Institute (IJC), Barcelona

Murillo-Sanjuán L:
 Pediatric Hematology and Oncology Division, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca, Barcelona

De Heredia CD:
 Pediatric Hematology and Oncology Division, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca, Barcelona

Pérez-Martinez A:
 Pediatric Department, Universidad Autonoma de Madrid, Madrid, Spain

 Hospital La Paz Institute for Health Research, Madrid, Spain

 Pediatric Hemato-Oncology Department, University Hospital La Paz, Madrid

López-Cadenas F:
 Servicio de Hematología Hospital Clínico Universitario de Salamanca, salamanca, Spain

 Instituto Biosanitario de Salamanca (IBSAL). Salamanca

Martínez-Laperche C:
 Servicio de Hematología, Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón, Madrid

Dorado-Herrero N:
 Servicio de Hematología, Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón, Madrid

Marco FM:
 Immunology Department, Dr. Balmis General University Hospital

 Institute for Health and Biomedical Research (ISABIAL), Alicante

Prósper F:
 Centro de Investigación Biomédica en Red de Oncología (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain

 Area de Hemato-Oncología, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain

 Servicio de Hematologia, CCUN, Clínica Universidad de Navarra, Universidad de Navarra, Pamplona

Menendez P:
 Centro de Investigación Biomédica en Red de Oncología (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain

 Josep Carreras Leukaemia Research Institute. Department of Biomedicine. School of Medicine, University of Barcelona, Barcelona, Spain

 Red Española de Terapias Avanzadas (TERAV) - Instituto de Salud Carlos III, Madrid, Spain

 Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona

Valcárcel D:
 Servei d'Hematologia, Vall d'Hebron Hospital Universitari

 Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO)

 Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona

Ballestar E:
 Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), Barcelona, Spain

 Epigenetics in Inflammatory and Metabolic Diseases Laboratory, Health Science Center (HSC), East China Normal University (ECNU), Shanghai

Bödör C:
 HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University. Budapest, Hungary

Bigas A:
 Centro de Investigación Biomédica en Red de Oncología (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain

 Programa de Investigación en Cáncer, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain

 Josep Carreras Leukaemia Research Institute (IJC), Barcelona

Català-Temprano A:
 Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid

 Department of Hematology and Oncology, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Deu, Barcelona, Spain

Wlodarski MW:
 Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN

Giorgetti A:
 Regenerative Medicine Program, Bellvitge Institute for Biomedical Research (IDIBELL) and Program for Clinical Translation of Regenerative Medicine in Catalonia (P-CMRC), Barcelona, Spain

 Fondazione Pisana Per la Scienza ONLUS (FPS), San Giuliano Terme, Italy

 Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Barcelona University, Barcelona.
ISSN: 03906078





HAEMATOLOGICA
Editorial
FERRATA STORTI FOUNDATION, VIA GIUSEPPE BELLI 4, 27100 PAVIA, ITALY, Italia
Tipo de documento: Letter
Volumen: 108 Número: 9
Páginas: 2551-2557
WOS Id: 001106208800033
ID de PubMed: 36815365
imagen Green Submitted, gold

MÉTRICAS